Article 101. Dossier and process for bioequivalence trial of a drug
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
Bioequivalence trial of drugs
1. A dossier for bioequivalence trial of a drug must comprise:
a/ A written request for bioequivalence trial of a drug;
b/ Documents on the drug’s information;
c/ A research outline for the bioequivalence trial and a written explanation;
d/ The researcher’s curriculum vitae;
dd/ An information sheet and the card of voluntary participation in the research of the participant in the trial;
e/ The label of the drug.
2. The process of bioequivalence trial of a drug is prescribed as follows:
a/ Registering the bioequivalence trial;
b/ Approving the bioequivalence trial;
c/ Organizing the bioequivalence trial;
d/ Approving the bioequivalence trial results.
3. The Minister of Health shall detail this Article.
XII
REGULATIONS AND QUALITY STANDARDS,
AND TESTING OF DRUGS, DRUG MATERIALS AND
PRIMARY PACKAGES OF DRUGS
Article 101, Law 105/2016/QH13